Publications by authors named "Cui Yun Su"
World J Oncol
December 2023
Article Synopsis
- This study investigates the effectiveness of combining first-line immunotherapy with chemotherapy for patients with extensive-stage small cell lung cancer (ES-SCLC), focusing on those with and without brain metastases.
- A review of seven randomized controlled trials found that patients without brain metastases experienced significant improvements in both progression-free survival (PFS) and overall survival (OS) when receiving the combination treatment compared to chemotherapy alone.
- In contrast, patients with brain metastases showed no significant benefits in PFS or OS from the addition of immunotherapy to their chemotherapy regimen.
Aging (Albany NY)
September 2023
Article Synopsis
- - The study investigates how the presence of liver metastases affects the survival outcomes of first-line immunotherapy combined with chemotherapy in patients with extensive stage small cell lung cancer (ES-SCLC).
- - Out of six analyzed trials involving 3,501 patients, results showed that while immunotherapy improved progression-free survival (PFS) and overall survival (OS) in patients without liver metastases, it did not provide significant benefits for those with liver metastases.
- - The conclusion emphasizes that first-line immunotherapy plus chemotherapy is beneficial for ES-SCLC patients without liver metastases, but offers little advantage for those with liver metastases.
